NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that pricing ...
AVXL Anavex Life Sciences Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback